Eberhard Schulz

12.5k total citations · 3 hit papers
177 papers, 9.8k citations indexed

About

Eberhard Schulz is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Eberhard Schulz has authored 177 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Physiology, 54 papers in Cardiology and Cardiovascular Medicine and 33 papers in Psychiatry and Mental health. Recurrent topics in Eberhard Schulz's work include Nitric Oxide and Endothelin Effects (51 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Cardiac Valve Diseases and Treatments (22 papers). Eberhard Schulz is often cited by papers focused on Nitric Oxide and Endothelin Effects (51 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Cardiac Valve Diseases and Treatments (22 papers). Eberhard Schulz collaborates with scholars based in Germany, United States and France. Eberhard Schulz's co-authors include Thomas Münzel, Andreas Daiber, Philip Wenzel, Matthias Oelze, John F. Keaney, Tommaso Gori, Swenja Kröller‐Schön, Thomas Jansen, Helmut Remschmidt and Maria Wendt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Eberhard Schulz

170 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1999 574 citations Georg Nickenig, Eberhard Schulz et al. Circulation profile →
Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling

2002 561 citations Hanke Mollnau, Maria Wendt et al. profile →
Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction

2011 407 citations Philip Wenzel, Maike Knorr et al. Circulation profile →

Peers

Countries citing papers authored by Eberhard Schulz

Since Specialization

Citations

This map shows the geographic impact of Eberhard Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Schulz more than expected).

Fields of papers citing papers by Eberhard Schulz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Schulz. The network helps show where Eberhard Schulz may publish in the future.

Co-authorship network of co-authors of Eberhard Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Schulz. A scholar is included among the top collaborators of Eberhard Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Schulz. Eberhard Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lack of Endothelial α1AMPK Reverses the Vascular Protective Effects of Exercise by Causing eNOS Uncoupling 2021 ·Antioxidants ·Thomas Jansen, Miroslava Kvandová, (unknown), Sanela Kalinovic, Paul Stamm, Marin Kuntić, Marc Foretz, Benoı̂t Viollet, Andreas Daiber, Matthias Oelze, John F. Keaney, Thomas Münzel, Eberhard Schulz, Swenja Kröller‐Schön	5
2	Direct comparison of inorganic nitrite and nitrate on vascular dysfunction and oxidative damage in experimental arterial hypertension 2021 ·Nitric Oxide ·Paul Stamm, Matthias Oelze, Sebastian Steven, Swenja Kröller‐Schön, Miroslava Kvandová, Sanela Kalinovic, Agnieszka Jasztal, Agnieszka Kij, Marin Kuntić, María Teresa Bayo Jiménez, Bartosz Proniewski, Huige Li, Eberhard Schulz, Stefan Chłopicki, Andreas Daiber, Thomas Münzel	20
3	Safety of Transradial and Transfemoral Left Ventricular Compared with Transfemoral Right Ventricular Endomyocardial Biopsy 2020 ·ESC Heart Failure ·Sebastian Göbel, (unknown), Thomas Jansen, Susanne Karbach, Tilman Emrich, Tommaso Gori, (unknown), Eberhard Schulz, Thomas Münzel, Karsten Keller, Philip Wenzel	8
4	Hydrogen Sulfide Affects Radical Formation in the Hippocampus of LPS Treated Rats and the Effect of Antipsychotics on Hydrogen Sulfide Forming Enzymes in Human Cell Lines 2018 ·Frontiers in Psychiatry ·Olaf Sommer, (unknown), Andreas Schmidt, Philip Heiser, Eberhard Schulz, Helmut Vedder, (unknown)	14
5	Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort 2017 ·International Journal of Cardiology ·Eberhard Schulz, Alexander Jabs, Alexander Tamm, (unknown), (unknown), Tommaso Gori, Stephan von Bardeleben, (unknown), Ulrich Hink, Christian‐Friedrich Vahl, Thomas Münzel	10
6	Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function 2015 ·British Journal of Pharmacology ·Andreas Daiber, Fabio Di Lisa, Matthias Oelze, Swenja Kröller‐Schön, Sebastian Steven, Eberhard Schulz, Thomas Münzel	213
7	Gliptin and GLP‐1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide‐induced endotoxemia 2015 ·Basic Research in Cardiology ·Sebastian Steven, Michael Hausding, Swenja Kröller‐Schön, Michael Mäder, Yuliya Mikhed, Paul Stamm, Elena Zinßius, (unknown), Philipp Welschof, (unknown), Stephan Sudowe, Huige Li, Matthias Oelze, Eberhard Schulz, Thomas Klein, Thomas Münzel, Andreas Daiber	99
8	Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison 2015 ·JACC: Cardiovascular Interventions ·Salvatore Brugaletta, Tommaso Gori, Adrian F. Low, Petr Toušek, Eduardo Pinar, Josep Gómez‐Lara, Giancarla Scalone, Eberhard Schulz, Mark Y. Chan, Viktor Kočka, José Hurtado, Thomas Münzel, Chi‐Hang Lee, Ángel Cequier, Mariano Valdés, Petr Widimský, Patrick W. Serruys, Manel Sabaté	115
9	Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes 2014 ·EuroIntervention ·Tommaso Gori, Eberhard Schulz, Ulrich Hink, Philip Wenzel, Felix Post, Alexander Jabs, Thomas Münzel	74
10	The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity 2014 ·PLoS ONE ·Matthias Oelze, Swenja Kröller‐Schön, Philipp Welschof, Thomas Jansen, Michael Hausding, Yuliya Mikhed, Paul Stamm, Michael Mäder, Elena Zinßius, (unknown), Anna Gottschlich, Sebastian Steven, Eberhard Schulz, Serge P. Bottari, Eric Mayoux, Thomas Münzel, Andreas Daiber	260
11	Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species—Studies in White Blood Cells and in Animal Models 2013 ·Antioxidants and Redox Signaling ·Swenja Kröller‐Schön, Sebastian Steven, Sabine Kossmann, Alexander Scholz, Steffen Daub, Matthias Oelze, Ning Xia, Michael Hausding, Yuliya Mikhed, Elena Zinßius, Michael Mäder, Paul Stamm, Nicolai Treiber, Karin Scharffetter‐Kochanek, Huige Li, Eberhard Schulz, Philip Wenzel, Thomas Münzel, Andreas Daiber	210
12	Mitochondrial Redox Signaling: Interaction of Mitochondrial Reactive Oxygen Species with Other Sources of Oxidative Stress 2012 ·Antioxidants and Redox Signaling ·Eberhard Schulz, Philip Wenzel, Thomas Münzel, Andreas Daiber	209
13	Abstract 13469: Alpha1-AMPK Deletion Enhances Endothelial Dysfunction and Vascular Oxidative Stress During Chronic Angiotensin II Treatment by Upregulation of Nox2 2010 ·Circulation ·Swenja Schuhmacher, Marc Foretz, Maike Knorr, Marcus Hortmann, Philip Wenzel, Matthias Oelze, Andreas Daiber, Thomas Münzel, Benoı̂t Viollet, Eberhard Schulz	1
14	A new class of organic nitrates: investigations on bioactivation, tolerance and cross‐tolerance phenomena 2009 ·British Journal of Pharmacology ·Swenja Schuhmacher, Eberhard Schulz, Matthias Oelze, Andreas König, (unknown), (unknown), (unknown), Toshihiro Kawamoto, Philip Wenzel, Thomas Münzel, J. Lehmann, Andreas Daiber	30
15	Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label Study 2008 ·Journal of Child and Adolescent Psychopharmacology ·Regina Dittmann, (unknown), Franz Joseph Freisleder, Helmut Remschmidt, Claudia Mehler‐Wex, (unknown), Ulrich Hagenah, Michael Schulte‐Markwort, Fritz Poustka, Martin H. Schmidt, Eberhard Schulz, (unknown), Peter M. Wehmeier	29
16	Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy 2005 ·Arteriosclerosis Thrombosis and Vascular Biology ·Hanke Mollnau, Matthias Oelze, Michael August, Maria Wendt, Andreas Daiber, Eberhard Schulz, Stephan Baldus, Andrei L. Kleschyov, (unknown), Philip Wenzel, Ulrich Hink, Georg Nickenig, Ingrid Fleming, Thomas Münzel	55
17	Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance 2004 ·Journal of Clinical Investigation ·Karsten Sydow, Andreas Daiber, Matthias Oelze, Zhiqiang Chen, Michael August, Maria Wendt, Volker Ullrich, Alexander Mülsch, Eberhard Schulz, John F. Keaney, Jonathan S. Stamler, Thomas Münzel	236
18	Determination of Clozapine and its Major Metabolites in Serum Samples of Adolescent Schizophrenic Patients by High-Performance Liquid Chromatography - Data from a Prospective Clinical Trial 1995 ·Pharmacopsychiatry ·Eberhard Schulz, Christian Fleischhaker, Helmut Remschmidt	28
19	An Open Trial of Clozapine in Thirty-Six Adolescents with Schizophrenia 1994 ·Journal of Child and Adolescent Psychopharmacology ·Helmut Remschmidt, Eberhard Schulz, (unknown)	54
20	Ursachen der Potenzierung der hypoglykmischen Wirkung von Sulfonylharnstoff-Derivaten durch Medikamente: II. Pharmakokinetik und Metabolismus von Glibenclamid (HB 419) in Gegenwart von Phenylbutazon 1971 ·European Journal of Clinical Pharmacology ·Eberhard Schulz, K. Koch, F. H. Schmidt	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact